Literature DB >> 12525539

In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome.

L Faivre1, R J Gorlin, M K Wirtz, M Godfrey, N Dagoneau, J R Samples, M Le Merrer, G Collod-Beroud, C Boileau, A Munnich, V Cormier-Daire.   

Abstract

Weill-Marchesani syndrome (WMS) is a connective tissue disorder characterised by short stature, brachydactyly, joint stiffness, and characteristic eye anomalies including microspherophakia, ectopia of the lenses, severe myopia, and glaucoma. Both autosomal recessive (AR) and autosomal dominant (AD) modes of inheritance have been described and a gene for AR WMS has recently been mapped to chromosome 19p13.3-p13.2. Here, we report on the exclusion of chromosome 19p13.3-p13.2 in a large AD WMS family and show that, despite clinical homogeneity, AD and AR WMS are genetically heterogeneous entities. Because two AD WMS families were consistent with linkage to chromosome 15q21.1, the fibrillin-1 gene was sequenced and a 24 nt in frame deletion within a latent transforming growth factor-beta1 binding protein (LTBP) motif of the fibrillin-1 gene was found in a AD WMS family (exon 41, 5074_5097del). This in frame deletion cosegregated with the disease and was not found in 186 controls. This study strongly suggests that AD WMS and Marfan syndrome are allelic conditions at the fibrillin-1 locus and adds to the remarkable clinical heterogeneity of type I fibrillinopathies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525539      PMCID: PMC1735272          DOI: 10.1136/jmg.40.1.34

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  93 in total

Review 1.  A bit of give and take: the relationship between the extracellular matrix and the developing chondrocyte.

Authors:  Danielle J Behonick; Zena Werb
Journal:  Mech Dev       Date:  2003-11       Impact factor: 1.882

2.  Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling.

Authors:  Clarissa S Craft; Wei Zou; Marcus Watkins; Susan Grimston; Michael D Brodt; Thomas J Broekelmann; Justin S Weinbaum; Steven L Teitelbaum; Richard A Pierce; Roberto Civitelli; Matthew J Silva; Robert P Mecham
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 4.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

5.  A case of Weill-Marchesani syndrome with inversion of chromosome 15.

Authors:  Jae Lim Chung; Sun Woong Kim; Ji Hyun Kim; Tae-Im Kim; Hyung Keun Lee; Eung Kweon Kim
Journal:  Korean J Ophthalmol       Date:  2007-12

6.  Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012.

Authors:  S Hoffjan
Journal:  Mol Syndromol       Date:  2012-06-12

Review 7.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

8.  Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach.

Authors:  Dirk Hubmacher; Eric Bergeron; Christine Fagotto-Kaufmann; Lynn Y Sakai; Dieter P Reinhardt
Journal:  Biomacromolecules       Date:  2014-03-07       Impact factor: 6.988

9.  Determination of the molecular basis of Marfan syndrome: a growth industry.

Authors:  Peter H Byers
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 10.  Biogenesis and function of fibrillin assemblies.

Authors:  Francesco Ramirez; Lynn Y Sakai
Journal:  Cell Tissue Res       Date:  2009-06-10       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.